Stock-Based Compensation (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2025

Dec. 31, 2024

Retirement Benefits [Abstract]

Schedule Of Stock Option Activity

The following table summarizes the Company’s stock option activity and related information:

	Number of Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value (in thousands)		Weighted Average Remaining Life
Outstanding, as of January 1, 2025		5,027,916	$	0.42	$	3,693,765		9.30
Granted		2,079,029	$	1.17	$	-		-
Exercised during period		609	$	0.42		-		-
Forfeited		56,503	$	0.76	$	-		-
Expired		-		-		-		-
Outstanding as of September 30, 2025		7,049,833	$	0.87	$	3,679,037		9.15

The following table summarizes the Company’s stock option activity and related information:

	Number of Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value (in thousands)		Weighted Average Remaining Life
Outstanding, as of January 1, 2023		272,844	$	11.70		-		8.15
Granted		-		-		-		-
Exercised during period		290	$	4.02		-		-
Forfeited		94,722	$	16.23		-		-
Expired		-		-		-		-
Outstanding, as of December 31, 2023		177,832	$	10.08	$	-		7.17
Granted		4,854,476	$	0.42	$	-		-
Exercised during period		-		-		-		-
Forfeited		5,418	$	0.42	$	-		-
Expired		-		-		-		-
Outstanding as of December 31, 2024		5,026,890	$	0.42	$	-		9.30

Schedule of Stock Options Valuation Assumptions

The estimated fair value of stock options was determined using the Black-Scholes option-pricing model with the following weighted-average assumptions:

	Nine Months Ended September 30,
	2025		2024
Expected term of options (years)	5-6.65		5-6.12
Expected volatility (%)		41.87-45.07		45.09-45.81
Risk-free interest rate (%)		3.83-3.99		4.57
Expected dividend yield (%)		—		—

The estimated fair value of stock options was determined using the Black-Scholes option-pricing model with the following weighted-average assumptions:

	Years Ended December 31,
	2024		2023
Expected term of options (years)	5-6.12
Expected volatility (%)		45.09-45.81
Risk-free interest rate (%)		4.57
Expected dividend yield (%)		—		—

Schedule of Stock Based Compensation Expenses

Total stock-based compensation expense for nine months ended on September 30, 2025 and 2024 was as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Cost of sales	$	2	$	2	$	10	$	5
Research and development		18		57		77		169
Sales and marketing		5		19		20		56
General and administrative		107		162		386		487
Total stock-based compensation expense	$	132	$	240	$	493	$	717

Total stock-based compensation expense for years ended December 31, 2024 and 2023 was as follows (in thousands):

	Years Ended December 31,
	2024		2023
Cost of sales		4		3
Research and development		153		123
Sales and marketing		115		66
General and administrative		689		143
Total stock-based compensation expense		961		335